Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apellis Pharmaceuticals (APLS) Change in Acquisitions & Divestments (2020 - 2022)

Apellis Pharmaceuticals filings provide 3 years of Change in Acquisitions & Divestments readings, the most recent being $125.0 million for Q4 2022.

  • For the quarter ending Q4 2022, Change in Acquisitions & Divestments rose 47.04% year-over-year to $125.0 million, compared with a TTM value of $393.3 million through Dec 2022, down 6.36%, and an annual FY2022 reading of $393.3 million, down 6.36% over the prior year.
  • Change in Acquisitions & Divestments hit $125.0 million in Q4 2022 for Apellis Pharmaceuticals, roughly flat from $125.0 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $312.5 million in Q4 2020, with the low at $25.0 million in Q1 2021.
  • Median Change in Acquisitions & Divestments over the past 3 years was $125.0 million (2022), compared with a mean of $132.8 million.
  • The sharpest move saw Change in Acquisitions & Divestments plummeted 72.8% in 2021, then surged 140.0% in 2022.
  • Year by year, Change in Acquisitions & Divestments stood at $312.5 million in 2020, then crashed by 72.8% to $85.0 million in 2021, then soared by 47.04% to $125.0 million in 2022.
  • According to Business Quant data, Change in Acquisitions & Divestments over the past three periods came in at $125.0 million, $125.0 million, and $83.3 million for Q4 2022, Q3 2022, and Q2 2022 respectively.